Social and economic costs of home parenteral nutrition

Background and aims: Home parenteral nutrition (HPN) is a lifesaving treatment for people with chronic intestinal failure. Although HPN has been studied from an economic point of view, the categories of costs usually included direct costs, frequently excluding personal costs and productivity costs. The purpose of the present paper was to study the total costs of HPN from a societal perspective. Methods: Observational, retrospective, transverse study of all adult patients who were on HPN for more than 3 months and were treated at Gregorio Maranon University Hospital (Madrid, Spain), from June 2018-2019. Data on personal costs and productivity costs were collected from questionnaires completed by patients receiving HPN. We also updated the direct healthcare and non-healthcare costs studied by our group previously to Euros ((sic)) for the year 2019. Results: Twenty-two patients were included. Personal costs were (sic)729.49 per patient ((sic)3.45 per patient per day) and productivity costs were (sic)256.39 per patient ((sic)1.21 per patient per day). Total HPN costs amounted to (sic)14,460.87 per patient ((sic)131.58 per patient per day). The direct healthcare and nonhealthcare costs accounted for 96.46% of overall costs, the personal costs for the patients receiving HPN accounted for 2.62% and productivity costs for 0.92%. Conclusions: From a societal perspective, the direct healthcare and non-healthcare costs accounted for the majority of HPN expenditure, followed by personal costs and productivity costs. (C) 2020 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.